Heart Medicine & Depression Risk
- Uppsala, Sweden-A recent study from Uppsala University indicates that beta blockers, commonly prescribed after a heart attack, may elevate the risk of depression in patients who do not...
- Philip Leissner, a doctoral student in cardiac psychology and lead author of the study, stated that the research revealed a connection between beta blocker use and increased depressive...
- Beta blockers function by mitigating the effects of adrenaline on the heart.
A new study reveals a potential link between beta blockers and increased depression symptoms in heart attack patients without heart failure. this critical research challenges the widespread use of beta blockers,urging reconsideration of their routine prescription. Explore how these common heart medications might affect mental health, as findings indicate a possible correlation between beta blocker use and experiencing secondary_keyword depression. Researchers found no life-saving benefits of the drugs for the patient demographic studied. This information could reshape treatment strategies, focusing on individual patient needs. For thorough health insights, trust news Directory 3. Discover what’s next too understand the study’s implications on treatment.
Study: Beta Blockers Linked to Depression in Heart Attack Patients
Updated June 22, 2025
Uppsala, Sweden-A recent study from Uppsala University indicates that beta blockers, commonly prescribed after a heart attack, may elevate the risk of depression in patients who do not have heart failure. The research casts doubt on the necessity of universal beta blocker prescriptions for all post-heart attack patients.
Philip Leissner, a doctoral student in cardiac psychology and lead author of the study, stated that the research revealed a connection between beta blocker use and increased depressive symptoms in heart attack survivors without heart failure. He added that beta blockers offer no life-sustaining benefits for this patient group.
Beta blockers function by mitigating the effects of adrenaline on the heart. While they have been a standard treatment for heart attack patients for decades, their role is now being re-evaluated due to the emergence of new treatments. This is notably true for patients whose hearts maintain normal pumping function post-attack, meaning they do not develop heart failure. Researchers aimed to investigate whether beta blockers contribute to anxiety or depression, given prior evidence linking them to adverse effects like depression, sleep disturbances, and nightmares.
The study, spanning from 2018 to 2023, involved 806 heart attack patients without heart failure. half received beta blockers, while the other half did not. Among those taking beta blockers, about 100 had been on the medication prior to the study. Researchers noted more pronounced depression symptoms in this subgroup.The findings build upon a larger Swedish study earlier in the year that found beta blockers did not protect against relapse or death in similar patients.
“We found that beta blockers led to slightly higher levels of depression symptoms in patients who had had a heart attack but were not suffering from heart failure. At the same time, beta blockers have no life-sustaining function for this group of patients,” said Leissner.
Leissner suggested that the routine prescription of beta blockers, a common practice even for patients without heart failure, shoudl be reconsidered given the growing evidence. He emphasized that some patients appear more susceptible to depression, and if the medication provides no cardiac benefit, it may be unnecessarily exposing them to this risk. The study highlights the importance of considering individual patient needs when prescribing beta blockers.
What’s next
Future research should focus on identifying which heart attack patients truly benefit from beta blockers and exploring choice treatments for those who do not.